Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Diabetes Medical Minute Topic 3: Incorporating CGM Into Practice
  • CME
  • CE

Credits Available
Physicians: maximum of 0.25 AMA PRA Category 1 Credits
Registered Nurses: 0.25 Nursing contact hours
Pharmacists: 0.25 contact hours (0.025 CEUs)
Released: March 20, 2020 Expiration: March 19, 2021
Start Activity
Provided by Endocrine Society

For questions about content or obtaining CME credit, please contact the Endocrine Society at www.education.endocrine.org/contact.

Produced in collaboration with
Supported by an educational grant from
Lilly
Vivian A. Fonseca, MD, FRCP
Program Director
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDE
Kushner_Pamela_32x32
Pamela Kushner, MD, FAAFP

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Explain the role of CGM in reducing postprandial hyperglycemia, increasing time in range, improving A1C, and reducing diabetes stress
  • Compare and contrast available and emerging CGM devices
  • Employ a stepped approach to reviewing and interpreting CGM data in order to develop a personalized management plan with patients
  • Collaborate with the diabetes healthcare team (ie, specialist, primary care clinician, diabetes educator) to improve adoption of CGM devices in practice

Information on this Educational Activity

Program Director

Vivian A. Fonseca, MD, FRCP

Tullis-Tulane Alumni Chair in Diabetes
Professor of Medicine
Chief,
Section of Endocrinology
Tulane University School of Medicine
New Orleans, Louisiana

Vivian A. Fonseca, MD, FRCP, has disclosed that he has received funds for research support (paid to his institution) from Bayer and Boehringer Ingelheim; has received consulting fees from Abbott, Asahi Kasei, AstraZeneca, Intarcia, Lilly, Novo Nordisk, Sanofi, and Takeda; and owns stock or stock options in Amgen, BRAVO4Health, Insulin Algorithms, and Microbiome Technologies.

Faculty

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDE

Clinical Pharmacy Specialist/CGM Program Coordinator
Department of Endocrinology, Diabetes, and Metabolism
Cleveland Clinic Diabetes Center
Cleveland, Ohio

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDE, has disclosed that she has received consulting fees from Dexcom, Novo, and LifeScan.
Pamela Kushner, MD, FAAFP

Clinical Professor
University of California Irvine Medical Center
Irvine, California
Director
Kushner Wellness
Los Alamitos, California

Pamela Kushner, MD, FAAFP, has disclosed that she has received consulting fees from AstraZeneca, Janssen, Lilly, and Novo Nordisk and fees for non-CME/CE services from AstraZeneca, Janssen, and Novo Nordisk.

Staff

Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, has no relevant conflicts of interest to report.
Kiran D. Mir-Hudgeons, PhD

Manager, Editorial Operations

Kiran Mir-Hudgeons, PhD, has no relevant conflicts of interest to report.
Megan Cartwright, PhD

Senior Clinical Editor

Megan Cartwright, PhD, has no relevant conflicts of interest to report.
Sharon Hwang, MD, MPH

Editorial Contributor

Sharon Hwang, MD MPH, has no relevant conflicts of interest to disclose.
Carolyn Skowronski, PharmD

Associate Director, Scientific Services

Carolyn Skowronski, PharmD, has no relevant conflicts of interest to report.

Target Audience

The target audience for these activities are endocrinologists (including MD, DO, NP, and PA), primary care clinicians (including MD, DO, NP, and PA), and other healthcare providers who are part of the diabetes care team including nurses, certified diabetes educators, pharmacists, and registered dieticians.

Goal

The goal of this activity is to improve learner knowledge and competence in managing glycemic control in patients with diabetes by providing timely treatment intensification according to the guidelines and applying evidence-based treatment strategies for patients with diabetes.

Physician Continuing Medical Education

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

The Association of Diabetes Care & Education Specialists is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This program provides 0.25 contact hour of continuing education credit.

Provider approved by the California Board of Registered Nursing, Provider #10977, for 0.25 Contact Hour. RNs must retain this document for 4 years after the activity concludes

Pharmacist Continuing Education

The Association of Diabetes Care & Education Specialists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 0.25 contact hour (.025 CEU's) of continuing education credit.

ACPE Universal Activity Number: 0069-9999-20-039-H01-P

Type of Activity: Knowledge

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 20, 2020, through March 19, 2021:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Diabetes Medical Minute Topic 3: Incorporating CGM Into Practice
  • CME
  • CE

Expert insights on when and how to integrate continuous glucose monitoring into the care of patients with type 1 and type 2 diabetes.
Vivian A. Fonseca, MD, FRCP
Program Director
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDE
Kushner_Pamela_32x32
Pamela Kushner, MD, FAAFP
Physicians: maximum of 0.25 AMA PRA Category 1 Credits
Registered Nurses: 0.25 Nursing contact hours
Pharmacists: 0.25 contact hours (0.025 CEUs)
Released: March 20, 2020 Expiration: March 19, 2021

Related Content

Concise CCO expert commentary on potential side effects with GLP-1 receptor agonists in patients with type 2 diabetes

Martin J. Abrahamson, MD, FACP Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: September 1, 2020 Expired: August 31, 2021

Neil Skolnik, MD reviews GLP-1 RAs to address elevated A1C, obesity, and CV risk, plus strategies to improve tolerability, adherence

John J. Russell, MD Neil Skolnik, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Nurse Practitioners: 1.0 AANP contact hour Released: July 13, 2020 Expired: July 12, 2021

Hyperglycemia can be a deadly complication for anyone with diabetes, but there are tools that can reduce this risk including GLP-1 medications. Learn more today.

Released: July 9, 2020

CME commentary: GLP-1 receptor agonists to prevent major cardiovascular adverse events (MACE) in type 2 diabetes (T2D), cardiovascular disease (CVD)

Anne Peters, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: June 8, 2020 Expired: June 7, 2021
Provided by Endocrine Society

For questions about content or obtaining CME credit, please contact the Endocrine Society at www.education.endocrine.org/contact.

Produced in collaboration with
Supported by an educational grant from
Lilly

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue